Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements6003Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4910Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10934 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 6003

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Tailored Digital Treatment for Migraine NCT05617339 · NCT05617339 Migraine Traitement symptomatique · Thérapie génique Non applicable UNKNOWN Background: An individualized internet-based treatment program from a biop… À vérifier ClinicalTrials.gov 2026-08-16 21:21:22 Détail
Transcutaneous Supraorbital Nerve Stimulator NCT05516251 · Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of… Migraine À vérifier Non applicable UNKNOWN Migraine has been ranked as the second most disabling neurological disorde… À vérifier ClinicalTrials.gov 2026-08-16 21:21:22 Détail
Levcromakalim NCT04905654 · Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura Migraine À vérifier Non applicable COMPLETED This study aims to explore the effect of Ivabradine on Levcromakalim-induc… À vérifier ClinicalTrials.gov 2026-08-16 21:21:21 Détail
Biofeedback NCT05454319 · CER-MIG-1 — Cerebri Biofeedback Feasibility Trial Migraine Thérapie génique Non applicable COMPLETED The purpose of this study is to investigate feasibility, usability, safety… À vérifier ClinicalTrials.gov 2026-08-16 21:21:20 Détail
DFN-15 Active NCT03006276 · Efficacy, Tolerability, and Safety Study of DFN-15 Migraine À vérifier Phase 3 COMPLETED Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or… À vérifier ClinicalTrials.gov 2026-08-16 21:21:20 Détail
DFN-15 Active NCT03009019 · Efficacy, Tolerability, and Safety of DFN-15 Migraine À vérifier Phase 3 COMPLETED Efficacy, Tolerability, and Safety of DFN-15 in episodic migraine with or… À vérifier ClinicalTrials.gov 2026-08-16 21:21:20 Détail
DST — The Effect of Daylight Saving Time Transitions on Sleep and Mig… NCT05742191 · NCT05742191 Migraine À vérifier À vérifier UNKNOWN A prospective study that investigates the impact of circadian rhythm distu… À vérifier ClinicalTrials.gov 2026-08-16 21:21:20 Détail
Galcanezumab NCT03963232 · PERSIST — A Study of Galcanezumab (LY2951742) in Participants With Episodic Migr… Migraine À vérifier Phase 3 COMPLETED The main purpose of this study is to evaluate the efficacy of the study dr… À vérifier ClinicalTrials.gov 2026-08-16 21:21:20 Détail
Ketone for Migraine Prevention NCT05085483 · NCT05085483 Migraine À vérifier Non applicable COMPLETED Efficacy of a nutritional ketogenic supplement (NKS) in reducing the numbe… À vérifier ClinicalTrials.gov 2026-08-16 21:21:20 Détail
miR-155 Expression in Episodic and Chronic Migraine NCT05891808 · NCT05891808 Migraine Ralentissement de la progression · Immunomodulation · Traitement symptomatique… À vérifier UNKNOWN Migraine is a common, yet often disabling, neurological disease that affec… À vérifier ClinicalTrials.gov 2026-08-16 21:21:20 Détail
AMG334 NCT03927144 · Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients Migraine À vérifier Phase 4 COMPLETED The purpose of this study is to compare the sustained long-term benefit be… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
Atogepant 60 mg NCT04740827 · ELEVATE — Atogepant for Prophylaxis of Migraine in Participants Who Failed Previ… Migraine À vérifier Phase 3 COMPLETED This goal of this study is to compare three medications used for migraine… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
CENSENMI — Presence of Signs of Central Sensitization in Episodic and… NCT05162664 · NCT05162664 Migraine À vérifier Non applicable COMPLETED Nowadays migraine is conceptualized as a continuum, with at the one hand e… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
Erenumab NCT04265755 · INTERROGATE — Biomarker and Genetic Predictors of Erenumab Treatment Response Migraine Traitement symptomatique Phase 4 COMPLETED The primary objective of this study is to evaluate the treatment benefit o… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
Galcanezumab NCT05127486 · CHALLENGE-MIG — A Study of Galcanezumab (LY2951742) in Adult Participants With E… Migraine À vérifier Phase 4 COMPLETED The main purpose of this study is to evaluate the efficacy of the study dr… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
greater occipital nerve block NCT06243874 · Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade Migraine Ralentissement de la progression · Traitement symptomatique Non applicable COMPLETED Migraine is one of the most prevalent neurological disorders worldwide and… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
MAbs NCT06562413 · SPHERA_WP1_2 — Searching for Novel Biological Phenotypes in Migraine Patients Re… Migraine Thérapie génique À vérifier RECRUITING Aim of the study was to assess a potential dysfunction of the endocannabid… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
MIGPHYSTREAT — Effectiveness of Multimodal Physical Therapy in Migrai… NCT05226559 · NCT05226559 Migraine Traitement symptomatique Non applicable UNKNOWN INTRODUCTION: It is very common that migraine patients could refer neck pa… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (… NCT06155123 · HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-… Migraine Ralentissement de la progression À vérifier UNKNOWN Migraine is a leading cause of disability with an estimated prevalence of… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
Research Study to Determine Sensitivity to Gentle Touch and Pressure… NCT00329771 · NCT00329771 Migraine À vérifier À vérifier COMPLETED Cutaneous allodynia (pronounced q-tane-ee-us all-o-din-ee-a) is common in… À vérifier ClinicalTrials.gov 2026-08-16 21:21:19 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4910

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
A comparative study of the role of crocin and sitagliptin in attenuat… Standard Oral Hypoglycemic Agent · PMID 31394428 Maladie rénale chronique Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose… Environmental toxicology and pharmacology 2026-11-15 04:38:02 Source
Anti diabetic effect of Achyranthes rubrofusca leaf extracts on allox… Standard Oral Hypoglycemic Agent · PMID 21454169 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source The aqueous and ethanolic extracts of Achyranthes rubrofuca leaves (AR) were studied for their hypoglycemic activity. T… Pakistan journal of pharmaceutical sciences 2026-11-15 04:38:02 Source
Antihyperglycemic and hypolipidemic activities of Setaria italica see… Standard Oral Hypoglycemic Agent · PMID 20869855 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu.… Pathophysiology : the official journal of the Internat… 2026-11-15 04:38:02 Source
Enhancing neoadjuvant immunotherapy for locally advanced rectal cance… HJB647 high dose · PMID 42860120 Cancer Immunomodulation Publication PubMed Voir la publication source Conventional surgery for locally advanced rectal cancer (LARC) faces challenges including difficult sphincter preservat… Biomaterials 2026-11-15 04:37:50 Source
Oxygen-vacancy-rich LDH sonosensitizers potentiate narrow-spectrum an… HJB647 high dose · PMID 42910182 Insuffisance cardiaque Neuroprotection · Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Mixed bacterial infections, including Gram-positive and Gram-negative pathogens, remain a major global health concern.… Bioactive materials 2026-11-15 04:37:50 Source
Respiratory Support With Nasal High Flow Reduces Opioid Requirements… HJB647 high dose · PMID 42699223 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source Nasal high flow (NHF) improves oxygenation, reduces the work of breathing, and stabilizes ventilation. In endoscopic re… DEN open 2026-11-15 04:37:50 Source
Feasibility of a Deep-Learning Model for Objective Visualization-Qual… Lithotripsy · PMID 42898633 Maladie coronarienne À vérifier Publication PubMed Voir la publication source During peroral cholangioscopy-guided electrohydraulic lithotripsy (EHL), stone fragmentation obscures the visual field… DEN open 2026-11-15 04:37:45 Source
Impact of calcium burden, lesion preparation, and lithotripsy on sten… Lithotripsy · PMID 42777787 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Stent underexpansion in severely calcified coronary lesions increases the risk of target vessel failure. Intravascular… International journal of cardiology 2026-11-15 04:37:45 Source
Intravascular lithotripsy for calcific stenosis of the abdominal aort… Lithotripsy · PMID 43001236 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Takayasu arteritis is a rare large-vessel vasculitis that predominantly affects the aorta and its major branches. Altho… Journal of vascular surgery cases and innovative techn… 2026-11-15 04:37:45 Source
Placenta-derived mesenchymal stem cells for prenatal myelomeningocele… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Thérapie cellulaire Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Annals of translational medicine 2026-11-15 04:37:41 Source
Synovial Biomarker Modulation and Clinical Response to Umbilical Cord… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source ObjectiveUmbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a promising treatment for knee osteoarthritis (… Cartilage 2026-11-15 04:37:41 Source
Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-c… B007 · PMID 42142713 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source The apelin receptor (AplnR) is a prominent peptide-binding Class A G protein-coupled receptor (GPCR) involved in the re… Bioorganic & medicinal chemistry letters 2026-11-15 04:37:34 Source
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral P… B007 · PMID 42467897 Myasthénie À vérifier Publication PubMed Voir la publication source Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because current antiviral th… Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026-11-15 04:37:34 Source
Understanding the Selectivity of Selective Oxidation of Propane to Ac… B007 · PMID 41768713 Myasthénie À vérifier Publication PubMed Voir la publication source In this work, we have performed a quantum chemical investigation for the selective oxidation of propane toward acrylic… ACS omega 2026-11-15 04:37:34 Source
Comparative efficacy and acceptability of antidepressants in the long… Milnacipran · PMID 43008763 Myopathies À vérifier Publication PubMed Voir la publication source Major depressive disorder carries high risks of relapse and chronicity, necessitating treatments that achieve and maint… The lancet. Psychiatry 2026-11-15 04:37:30 Source
Polysubstance-Induced Vasoplegia Managed with Venoarterial Extracorpo… Milnacipran · PMID 43014364 Myopathies À vérifier Publication PubMed Voir la publication source While the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) becomes increasingly commonplace in overdos… Clinical practice and cases in emergency medicine 2026-11-15 04:37:30 Source
Early Outcome of a Single Peri-Tendinous Hyaluronic Acid Injection fo… Sodium hyaluronate with mannitol (Ostenil Tendon) · PMID 33132010 Myopathies Traitement symptomatique Publication PubMed Voir la publication source The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid… Foot (Edinburgh, Scotland) 2026-11-15 04:37:29 Source
Engineered stem cell-derived CD16-enhanced universal NKT cells improv… Tafasitamab and NK cells · PMID 43008138 Cancer Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Monoclonal antibody (mAb)-based therapies have revolutionized cancer treatment; however, their clinical efficacy is oft… Cancer immunology research 2026-11-15 04:37:24 Source
Precision Fc remodeling via glycosylation-competent CHO display enabl… Tafasitamab and NK cells · PMID 41923108 Cancer Immunomodulation Publication PubMed Voir la publication source BACKGROUND: Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-ty… Journal of biological engineering 2026-11-15 04:37:24 Source
The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural kil… Tafasitamab and NK cells · PMID 23277329 Lupus À vérifier Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Leukemia 2026-11-15 04:37:24 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.